Hls Therapeutics Inc.

Hls Therapeutics Inc. company information, Employees & Contact Information

Stewards of Trusted Brands HLS Therapeutics Inc. (TSX:HLS) specializes in the acquisition and commercialization of pharmaceuticals focused on addressing unmet needs in the treatment of psychiatric disorders and cardiovascular disease. We are dedicated to introducing novel therapies in Canada and the United States and ensuring that trusted branded medicines are readily accessible to healthcare providers & patients. Led by a team of executives with deep expertise in product development and commercialization, HLS Therapeutics Inc. maintains operational locations in the Toronto, Montreal, and Philadelphia metropolitan areas. Experienced across all stages of the product lifecycle Our team has a wealth of experience with each stage of the pharmaceutical lifecycle, from late-stage development to new product launch and commercial-stage promotion. Our team is committed to expanding access to quality treatments critical to healthcare providers, patients, and their caregivers.

Company Details

Employees
91
Founded
-
Address
10 Carlson Court, Suite 410,canada
Phone
(416) 624-6568
Email
g.****@****ics.com
Industry
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
In-Vitro Diagnostic Substance Manufacturing
Biological Product (except Diagnostic) Manufacturing
HQ
Etobicoke, ON
Looking for a particular Hls Therapeutics Inc. employee's phone or email?

Hls Therapeutics Inc. Questions

News

HLS Therapeutics and Amarin Collaborate on Presenting REDUCE-IT® and EPA Mechanistic Data at the Canadian Cardiovascular Congress - Yahoo Finance

HLS Therapeutics and Amarin Collaborate on Presenting REDUCE-IT® and EPA Mechanistic Data at the Canadian Cardiovascular Congress Yahoo Finance

Esperion Enters License Agreement with HLS Therapeutics to Expand Access to Bempedoic Acid Products in Canada - Quiver Quantitative

Esperion Enters License Agreement with HLS Therapeutics to Expand Access to Bempedoic Acid Products in Canada Quiver Quantitative

HLS Therapeutics Announces Q1 2025 Financial Results - Yahoo Finance

HLS Therapeutics Announces Q1 2025 Financial Results Yahoo Finance

HLS Therapeutics partners with Esperion Therapeutics to commercialize NEXLETOL® and NEXLIZET® in Canada - Yahoo Finance

HLS Therapeutics partners with Esperion Therapeutics to commercialize NEXLETOL® and NEXLIZET® in Canada Yahoo Finance

The past five years for HLS Therapeutics (TSE:HLS) investors has not been profitable - Yahoo Finance

The past five years for HLS Therapeutics (TSE:HLS) investors has not been profitable Yahoo Finance

HLS Therapeutics stock is over a triple from here, says Stifel - Cantech Letter

HLS Therapeutics stock is over a triple from here, says Stifel Cantech Letter

Top Hls Therapeutics Inc. Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant